NCT03866499 2024-08-07
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
Beta Pharma, Inc.
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT03812809 2022-05-19
A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive
Beta Pharma, Inc.
Phase 2 Completed
NCT03386955 2022-05-16
BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer
Beta Pharma, Inc.
Phase 1/2 Completed